{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+propionate+500+mcg", "query": { "intervention": "Fluticasone propionate 500 mcg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+propionate+500+mcg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-30T02:20:27.509Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01225913", "title": "Mechanism(s) of Airflow Limitation During Exacerbation of Asthma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone/salmeterol in all asthmatics", "type": "DRUG" }, { "name": "budesonide/formoterol or fluticasone/salmeterol in all asthmatics", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gelb, Arthur F., M.D.", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "10 Years to 80 Years" }, "enrollment_count": 50, "start_date": "2007-10", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2023-10-26", "last_synced_at": "2026-09-30T02:20:27.509Z", "location_count": 1, "location_summary": "Lakewood, California", "locations": [ { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01225913" }, { "nct_id": "NCT00318708", "title": "Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "clarithromycin", "type": "DRUG" }, { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "placebo clarithromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 92, "start_date": "2006-06", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2018-03-23", "last_synced_at": "2026-09-30T02:20:27.509Z", "location_count": 10, "location_summary": "San Diego, California • San Francisco, California • Denver, Colorado + 7 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00318708" }, { "nct_id": "NCT03207243", "title": "Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "GSK3772847", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 165, "start_date": "2017-09-14", "completion_date": "2019-05-15", "has_results": true, "last_update_posted_date": "2020-03-02", "last_synced_at": "2026-09-30T02:20:27.509Z", "location_count": 33, "location_summary": "Birmingham, Alabama • Scottsboro, Alabama • Bakersfield, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsboro", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03207243" }, { "nct_id": "NCT01576718", "title": "A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fp MDPI", "type": "DRUG" }, { "name": "Placebo MDPI", "type": "OTHER" }, { "name": "Flovent Diskus", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 889, "start_date": "2012-04", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2018-05-08", "last_synced_at": "2026-09-30T02:20:27.509Z", "location_count": 148, "location_summary": "Birmingham, Alabama • Homewood, Alabama • Goodyear, Arizona + 114 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01576718" }, { "nct_id": "NCT01725685", "title": "To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FF 400 mcg", "type": "DRUG" }, { "name": "UMEC 500 mcg", "type": "DRUG" }, { "name": "FF/UMEC 400/500 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 18, "start_date": "2012-11-08", "completion_date": "2013-01-02", "has_results": false, "last_update_posted_date": "2017-06-09", "last_synced_at": "2026-09-30T02:20:27.509Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01725685" }, { "nct_id": "NCT01967173", "title": "Best African American Response to Asthma Drugs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Flovent Diskus® 100 mcg", "type": "DRUG" }, { "name": "Flovent Diskus® 250 mcg", "type": "DRUG" }, { "name": "Flovent Diskus® 500 mcg", "type": "DRUG" }, { "name": "Advair Diskus® 100/50 mcg", "type": "DRUG" }, { "name": "Advair Diskus® 250/50 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 574, "start_date": "2014-02", "completion_date": "2017-07-01", "has_results": true, "last_update_posted_date": "2018-11-15", "last_synced_at": "2026-09-30T02:20:27.509Z", "location_count": 28, "location_summary": "Tucson, Arizona • Oakland, California • San Francisco, California + 16 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Oakland", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01967173" }, { "nct_id": "NCT02437604", "title": "Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Treatment A: Fp MDPI", "type": "DRUG" }, { "name": "Treatment B: FS MDPI", "type": "DRUG" }, { "name": "Treatment C Flovent", "type": "DRUG" }, { "name": "Treatment D: Advair", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 43, "start_date": "2015-05", "completion_date": "2015-09", "has_results": false, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-30T02:20:27.509Z", "location_count": 3, "location_summary": "Raleigh, North Carolina • Edmond, Oklahoma • San Antonio, Texas", "locations": [ { "city": "Raleigh", "state": "North Carolina" }, { "city": "Edmond", "state": "Oklahoma" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02437604" }, { "nct_id": "NCT01430403", "title": "Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Omalizumab", "type": "BIOLOGICAL" }, { "name": "Inhaled Corticosteroid Boost Therapy (ICS)", "type": "DRUG" }, { "name": "Placebo omalizumab", "type": "BIOLOGICAL" }, { "name": "Placebo fluticasone", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 478, "start_date": "2011-09", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-09-30T02:20:27.509Z", "location_count": 8, "location_summary": "Denver, Colorado • Washington D.C., District of Columbia • Chicago, Illinois + 5 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01430403" }, { "nct_id": "NCT01894386", "title": "Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "FF 400 mcg", "type": "DRUG" }, { "name": "UMEC 500 mcg", "type": "DRUG" }, { "name": "UMEC 250 mcg", "type": "DRUG" }, { "name": "VI 100 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 48, "start_date": "2013-07-15", "completion_date": "2013-09-26", "has_results": false, "last_update_posted_date": "2017-05-15", "last_synced_at": "2026-09-30T02:20:27.509Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01894386" }, { "nct_id": "NCT01875003", "title": "A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Lebrikizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of Care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 346, "start_date": "2013-08-13", "completion_date": "2016-12-28", "has_results": true, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-09-30T02:20:27.509Z", "location_count": 16, "location_summary": "Mission Viejo, California • Stockton, California • Aurora, Colorado + 12 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Centennial", "state": "Colorado" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01875003" } ] }